news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Hello everyone! Let's pay attention to the market conditions and latest information in the morning~

As the end of the month approaches, the central bank continues to release liquidity: on August 27, the central bank conducted a 7-day reverse repurchase operation of 472.5 billion yuan in a fixed interest rate and quantity bidding method, with an operating interest rate of 1.70%. Wind data showed that a total of 149.1 billion yuan of reverse repurchases matured on that day.

In the market, A-shares opened slightly lower in the morning: the Shanghai Composite Index fell 0.16%, the Shenzhen Component Index fell 0.4%, and the ChiNext Index fell 0.49%. The market fluctuated in a narrow range in the morning, and the ChiNext Index continued to decline, falling more than 1% during the session.

On the market, oil and gas, coal, medicine, banking and other sectors rose in the morning, and concepts such as vaccines, biotechnology, and online games rose the most. Precious metals led the decline, real estate, agriculture, aviation and other sectors were sluggish, and lithium battery concepts collectively pulled back.

Hong Kong stocks opened lower in the morning: the Hang Seng Index fell 0.76%, the Hang Seng Technology Index fell 1.35%, and the Hang Seng China Enterprises Index fell 0.89%. As of press time, the Hang Seng Index's decline narrowed slightly, and JD.com, Alibaba, and Meituan all fell by more than 4%.

Pharmaceutical sectors collectively rose

On August 27, the A-share pharmaceutical sector rose in early trading, with monkeypox, generic drugs, and biotechnology concepts leading the gains.

In terms of individual stocks, Haichen Pharmaceutical and Hualan Vaccine hit the 20CM daily limit, Shuangcheng Pharmaceutical, Hefu China, Asia Pacific Pharmaceutical, Tus Pharmaceuticals and many other stocks hit the daily limit, and Jindik and Puli Pharmaceuticals rose by more than 10%.

On the news front, the World Health Organization launched a global strategic preparedness and response plan on August 26 to prevent the spread of monkeypox between people through global, regional and national coordinated efforts. According to reports, the plan covers six months from September 2024 to February 2025 and is expected to require $135 million in response funds. WHO headquarters and regional offices have established incident management support teams and significantly increased staff to affected countries.

Previously, World Health Organization Director-General Tedros Adhanom Ghebreyesus announced on August 14 that the monkeypox epidemic constituted an "international public health emergency". On August 15, the General Administration of Customs issued the Announcement No. 107 of 2024 on Preventing the Introduction of Monkeypox into my country.

According to a research report by Everbright Securities, timely and effective testing will help to take timely control measures and reduce the risk of virus transmission. It is recommended to pay attention to related companies whose monkeypox testing products have obtained CE certification.

Huawei's industry chain is active

Shenzhen Huaqiang rises for 9 consecutive days

On the morning of August 27, A-share stocks related to Huawei's industrial chain continued to be active. Huizhong shares rose by 20CM, Ningshui Group, Changshan Beiming, Kesen Technology and others rose by the daily limit, and Shenzhou Taiyue and Green Alliance Technology followed suit.

Influenced by the popularity of Huawei HiSilicon, Shenzhen Huaqiang has recently come out of 9 consecutive gains. As of press time, Shenzhen Huaqiang's share price is 20.54 yuan per share, an increase of 10.02%, and its total market value has risen to 21.5 billion yuan.

Previously, an investor asked Shenzhen Huaqiang on the interactive platform: What are the Huawei HiSilicon products that the company represents? Shenzhen Huaqiang said that the company's products cover the fields of smart vision, smart media, display interaction, MCU, simulation, smart perception, short-range IoT, wide-area IoT, mobile phones and wearables, and smart home.

After the market closed on August 26, Shenzhen Huaqiang issued an announcement on abnormal stock trading fluctuations, saying that the company's stock price has risen sharply in the short term, while the company's fundamentals have not changed significantly recently. Shenzhen Huaqiang reminds investors: stock prices may be affected by multiple factors such as the macro environment, industry development, company operating conditions and investor preferences. Investors are advised to pay attention to trading risks, make prudent decisions and invest rationally.

Privatization failed

Asia Cement (China) plunges

On August 27, Asia Cement (China) opened with a sharp drop of nearly 14% in the morning. The stock price continued to fall in the morning, and the intraday decline once exceeded 29%. The lowest stock price was HK$2.13 per share.

On the evening of August 26, Asia Cement (China) announced that the resolution proposed by the controlling shareholder Asia Cement Co., Ltd. to privatize the company by way of a scheme of arrangement was not approved by the plan shareholders at the court meeting. The proposal and the plan have become invalid, the proposal will not be implemented and the plan will not take effect.

Asia Cement (China) stated in the announcement that the listing status of the company's shares on the Hong Kong Stock Exchange will not be revoked, and the company will not suspend the share transfer registration procedures for determining the rights of the plan shareholders under the plan from Wednesday, September 4, 2024.

According to the Takeover Code, the offeror shall not announce another offer for the shares within 12 months. In addition, Asia Cement (China) previously disclosed its 2024 interim results, with revenue of 2.689 billion yuan, a year-on-year decrease of 34.49%; the loss attributable to shareholders was 405 million yuan, and the profit attributable to shareholders in the same period last year was 196 million yuan, turning from profit to loss year-on-year.